RECRUITINGINTERVENTIONAL
Cervical Cancer Detection Using Optical Spectroscopy
About This Trial
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
Who May Be Eligible (Plain English)
Who May Qualify:
- undergoing colposcopy for the diagnosis of cervical cancer
- LEEP for the treatment of cervical cancer in early stages.
- Follow-up Pap smear in surveillance
Who Should NOT Join This Trial:
- Women under the age of 18 (minors) will be excluded from this study.
- patients will be excluded if she has had a recent episode of bleeding or preterm labor.
- Subjects who are not competent to give consent will excluded
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* undergoing colposcopy for the diagnosis of cervical cancer
* LEEP for the treatment of cervical cancer in early stages.
* Follow-up Pap smear in surveillance
Exclusion Criteria:
* Women under the age of 18 (minors) will be excluded from this study.
* patients will be excluded if she has had a recent episode of bleeding or preterm labor.
* Subjects who are not competent to give consent will excluded
Treatments Being Tested
DEVICE
Optical Spectroscopy Bench-Top System
This device is a bench-top optical spectrometer
DEVICE
Portable Optical Spectrometer
This device is a portable optical spectrometer
DEVICE
Transvaginal colposcope
Locations (1)
Duke University Medical Center
Durham, North Carolina, United States